NEW YORK (GenomeWeb) – Immunoassay firm Gyros and peptide synthesis company Protein Technologies said today that they have entered into a definitive merger agreement to form Gyros Protein Technologies.

The company will combine Gyro's microfluidics, systems development, and immunoassay experience with Protein Technologies' peptide synthesis expertise to provide sample prep, synthesis, and bioanalytical tools for biotherapeutics discovery, development, and bioprocessing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

Sponsored by

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.